Related Articles
<sup>18</sup>F‑FDG PET/CT SUV<sub>max</sub> and serum CEA levels as predictors for EGFR mutation state in Chinese patients with non‑small cell lung cancer
Comparison of the efficacy of icotinib in patients with non‑small‑cell lung cancer according to the type of epidermal growth factor receptor mutation
Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer
Determination of EGFR and KRAS mutational status in Greek non‑small‑cell lung cancer patients
Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma